• OPEN AN ACCOUNT
Indian Indices
Sensex
76,502.46 809.68
( 1.07%)
Global Indices
Nasdaq
52,165.19 373.88
(0.72%)
Dow Jones
7,596.72 -4.35
(-0.06%)
Hang Seng
63,112.86 -177.25
(-0.28%)
Nikkei 225
10,768.78 39.00
(0.36%)
Forex
USD-INR
94.93 -0.28
(-0.30%)
EUR-INR
105.90 -0.29
(-0.27%)
GBP-INR
127.09 0.08
(0.06%)
JPY-INR
0.60 0.00
(-0.15%)

EQUITY - MARKET SCREENER

Shri Hare-Krishna Sponge Iron Ltd
Industry :  Steel - Sponge Iron
BSE Code
ISIN Demat
Book Value()
94049
INE0NON01025
55.5672306
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SHKSIL
8.05
49.9
EPS(TTM)
Face Value()
Div & Yield %
3.23
10
0
 

Lupin receives USFDA approval for Modafinil Tablets USP
Sep 04,2026
Lupin has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA) for Modafinil Tablets USP, 100 mg and 200 mg.

The U.S. FDA has approved Lupin's Modafinil Tablets USP, 100 mg and 200 mg as bioequivalent to the reference listed drug (RLD), Provigil® Tablets of Nuvo Pharmaceuticals (Ireland) DAC, and is indicated to improve wakefulness in adult patients with excessive sleepiness associated with narcolepsy, obstructive sleep apnea (OSA) or shift work disorder (SWD).

Modafinil Tablets (RLD Provigil®) had estimated annual sales of USD 70.7 million in the U.S. (IQVIA MAT Jul 2026).